Table 12.12

Adjusted Patient Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2003 - 2004) (Tx 2003 - 2004) (Tx 2001 - 2004) (Tx 1999 - 2004)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,151 93.5% 0.5% 2,151 85.3% 0.8% 4,161 66.4% 0.9% 5,925 50.9% 0.9%
Primary Diagnosis Emphysema/COPD 839 94.9% 0.8% 839 88.2% 1.2% 1,705 69.7% 1.4% 2,483 51.9% 1.5%
Cystic Fibrosis 348 94.7% 1.4% 348 84.8% 2.5% 649 67.5% 2.7% 941 51.1% 2.7%
Idiopathic Pulmonary Fibrosis 504 91.3% 1.3% 504 80.7% 1.8% 870 61.5% 2.1% 1,149 47.6% 2.2%
Alpha-1-Antitrypsin Deficiency 118 94.0% 2.2% 118 91.4% 2.6% 278 69.3% 3.2% 412 54.6% 3.4%
Primary Pulmonary Hypertension 74 81.2% 4.7% 74 77.0% 5.1% 155 62.6% 4.4% 230 53.6% 4.2%
Congenital Disease 17 100.0% 0.0% 17 87.1% 8.3% 33 58.5% 10.5% 61 47.8% 7.9%
Other 229 93.2% 1.7% 229 81.3% 2.7% 448 63.7% 2.8% 623 54.7% 2.6%
Unknown 22 81.8% 8.0% 22 72.8% 9.3% 23 69.6% 9.3% 26 69.1% 8.8%


Source: OPTN/SRTR Data as of May 1, 2006.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.